GR1003550B - Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων - Google Patents

Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων

Info

Publication number
GR1003550B
GR1003550B GR990100317A GR990100317A GR1003550B GR 1003550 B GR1003550 B GR 1003550B GR 990100317 A GR990100317 A GR 990100317A GR 990100317 A GR990100317 A GR 990100317A GR 1003550 B GR1003550 B GR 1003550B
Authority
GR
Greece
Prior art keywords
concoction
penta
gums
stable
tetra
Prior art date
Application number
GR990100317A
Other languages
English (en)
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR1003550B publication Critical patent/GR1003550B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Σταθερό φαρμακευτικό παρασκεύασμα ισοεξυλοναφθαζαρινών με πεντα-και τετρα-κυκλικά τριτερπένια, συστατικά φυτικών ελαιορητίνων και κόμμεων. Ενα σταθερό φαρμακευτικό παρασκεύασμα ενός παραγώγου ισοεξυλοναφθαζαρίνης το οποίο περιέχει ως δραστικά συστατικά ισοεξυλοναφθαζαρίνες ή/και εστερικά παράγωγα από τα αλκοολικά υδροξύλια της αλυσίδας του γενικού τύπου <*>με την προσθήκη πεντα- και τετρα- κυκλικών τριτερπενίων ή καλύτερα ενσωματούμενες σε τετηγμένες ελαιορητίνες και κόμμεα των ρητινοφόρων ειδών του γένους Pistacia. Οι ισοεξυλοναφθαζαρίνες και τα παράγωγά τους είναι χρήσιμα επουλωτικά φάρμακα, αλλά παρουσιάζουν ευαισθησία στη θερμότητα, στο οξυγόνο και κυρίως στο φως. Ενα σταθερό παρασκεύασμα ισοεξυλοναφθαζαρινών λαμβάνεται με διάλυση σε ελαιόλαδο και προσθήκη ελαιορητινών και κόμμεων πλούσιων σε πεντα- και τετρα- κυκλικά τριτερπένια με ευφανικό, ολεανικό, ουρσανικό, λανοστανικό, λουπανικό και δαμμαρανικό σκελετό.ΰ
GR990100317A 1999-09-22 1999-09-22 Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων GR1003550B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100317 1999-09-22

Publications (1)

Publication Number Publication Date
GR1003550B true GR1003550B (el) 2001-03-13

Family

ID=10943919

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100317A GR1003550B (el) 1999-09-22 1999-09-22 Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων

Country Status (3)

Country Link
EP (1) EP1137440A1 (el)
GR (1) GR1003550B (el)
WO (1) WO2001021212A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1003868B (el) * 2001-02-06 2002-04-19 Lavipharm S.A. Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
EP1501527B1 (en) * 2002-05-01 2009-09-02 Lavipharm S.A. Use of mastic and its essential oils for the control of microbial infections
PL2403512T3 (pl) 2009-03-04 2019-10-31 Regenera Pharma Ltd Kompozycje polimerowego mircenu
WO2010100650A2 (en) 2009-03-04 2010-09-10 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
EP2283805A1 (en) 2009-07-28 2011-02-16 Sirvis BV Compositions comprising a zinc containing compound dissolved in a hydrophobic phase
KR101910781B1 (ko) 2010-09-07 2018-10-22 레제네라 파마 리미티드 매스틱 검의 산성 추출물을 포함하는 조성물
WO2017069715A1 (en) * 2015-10-22 2017-04-27 Ataturk Universitesi Bilimsel Arastirma Projeleri Birimi Wound care composition
CN113480590B (zh) * 2021-08-12 2023-02-17 云南西力生物技术股份有限公司 雷公藤大戟酮(wilfordeuphone)及其制备方法和在药物上的应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2376660A1 (fr) * 1977-01-07 1978-08-04 Papageorgiou Vassilios Medicament a base d'alkannine, de shikonine ou de derives de ces substances, soignant les lesions cutanees de diverses origines
DE2829744A1 (de) * 1978-01-05 1979-07-19 Papageorgiou Vassilios P-dihydroxynaphtochinonderivate
DE2831786A1 (de) * 1978-07-19 1980-02-07 Papageorgiou Vassilios P-dihydroxynaphtochinonderivate und verfahren zu ihrer herstellung
JPS56161320A (en) * 1980-05-17 1981-12-11 Toko Yakuhin Kogyo Kk Cold feeling stimulating cataplasm
JPS60181025A (ja) * 1984-02-29 1985-09-14 Nitto Electric Ind Co Ltd 外用薬
JPH04128219A (ja) * 1990-09-18 1992-04-28 Dia Seiyaku Kk 皮膚潰瘍治療用貼付剤
WO1995002572A1 (en) * 1993-07-14 1995-01-26 Byung Zun Ahn Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
CN1131018A (zh) * 1995-03-15 1996-09-18 吕建军 消炎清创药物组合物

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2376660A1 (fr) * 1977-01-07 1978-08-04 Papageorgiou Vassilios Medicament a base d'alkannine, de shikonine ou de derives de ces substances, soignant les lesions cutanees de diverses origines
DE2829744A1 (de) * 1978-01-05 1979-07-19 Papageorgiou Vassilios P-dihydroxynaphtochinonderivate
DE2831786A1 (de) * 1978-07-19 1980-02-07 Papageorgiou Vassilios P-dihydroxynaphtochinonderivate und verfahren zu ihrer herstellung
JPS56161320A (en) * 1980-05-17 1981-12-11 Toko Yakuhin Kogyo Kk Cold feeling stimulating cataplasm
JPS60181025A (ja) * 1984-02-29 1985-09-14 Nitto Electric Ind Co Ltd 外用薬
JPH04128219A (ja) * 1990-09-18 1992-04-28 Dia Seiyaku Kk 皮膚潰瘍治療用貼付剤
WO1995002572A1 (en) * 1993-07-14 1995-01-26 Byung Zun Ahn Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
CN1131018A (zh) * 1995-03-15 1996-09-18 吕建军 消炎清创药物组合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198204, Derwent World Patents Index; Class B05, AN 1982-06729E, XP002138371 *
DATABASE WPI Section Ch Week 198543, Derwent World Patents Index; Class B04, AN 1985-267441, XP002138372 *
DATABASE WPI Section Ch Week 199223, Derwent World Patents Index; Class A96, AN 1992-190095, XP002138373 *
DATABASE WPI Section Ch Week 199801, Derwent World Patents Index; Class B04, AN 1998-000260, XP002138374 *

Also Published As

Publication number Publication date
EP1137440A1 (en) 2001-10-04
WO2001021212A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
MX9704988A (es) Derivados de hidroxilamina utiles para mejorar la produccion del acompañante molecular y la preparacion de los mismos.
DE69427708D1 (de) Stabilisierte arzneizusammensetzung enthaltend 10-hydroxy-7-ethylcamptothecin als lakton-verbindung
EP1496076A4 (en) HYDROPHILIC Y-BRANCH POLYMER DERIVATIVE AND METHOD OF MANUFACTURING THEREOF; ABOVE CONNECTED MEDICAL COMPOSITE
DE50005515D1 (de) Mechanisch stabile pharmazeutische darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive substanzen
BR0314898A (pt) Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
ES2160577T3 (es) Nuevos esteres de aminoalcoholes biciclicos y triciclicos, su preparacion y su utilizacion en medicamentos.
DE60030263D1 (de) Neue phosphor enthaltende medikamentenvorläuferverbindungen
BR9807383A (pt) Formulação farmacêutica que compreende amoxicilina e clavulanato
ES2098004T3 (es) Peptidos derivados de trifluoro-metil-cetonas con una actividad inhibidora de la elastasa leucocitaria humana (hle), su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE202931T1 (de) Taxanderivate enthaltende arzneizubereitungen
GR1003550B (el) Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
KR970025615A (ko) 암 전이 억제제
IL95444A0 (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents,their preparation and pharmaceutical compositions containing them
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8600658D0 (sv) Novel composition of matter
DK1242067T3 (da) Calciumformiat som et kosttilskud
HU9203022D0 (en) Pharmaceutical preparatives with upriflavone content methods for production and medical utilization of said compounds
EA200000261A3 (ru) Новые замещенные димерные соединения, способ их получения и содержащияся их фармацевтическая композиция
GR3023941T3 (en) Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions.
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
ES2072910T3 (es) Utilizacion de un compuesto que contiene germanio organico para la fabricacion de un medicamento para el tratamiento del sida.
ATE59038T1 (de) Taurinderivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
ES2071843T3 (es) Derivado de acido d-2-(6-metoxi-2-naftil)-propionico opticamente activo y composiciones farmaceuticas que lo contienen.
ATE359284T1 (de) Neue verbindungen, bei denen es sich um modulatoren von rezeptoren vom ppar-typ handelt, und deren verwendung in kosmetischen oder pharmazeutischen zusammensetzungen

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20110404